In a new study involving 198 contrast-enhanced mammography exams in 104 women with breast implants, researchers noted that only one patient had a complication.
For women with breast implants, new research suggests that contrast-enhanced mammography (CEM) can be a viable screening option with negligible side effects.
In a recently published study in Clinical Imaging, researchers performed 198 CEM exams in 104 women with breast implants. The researchers noted that 67 percent of the women had silicone implants, 31 percent had saline implants and two percent had both. Ninety percent of the study cohort had subpectoral implants and 10 percent had retroglandular implants, according to the study. The study authors also pointed out that 93 percent of the study participants had dense breasts.
The study authors noted no complications in 99.5 percent of the CEM exams. While one patient had mild vasovagal symptoms after contrast administration, the researchers said she was able to complete the mammography exam.
“(Contrast-enhanced mammography) is technically feasible and may serve as a good alternative for those women at increased risk who cannot undergo screening with MRI,” summarized Maxine S. Jochelson, M.D., chief of the Breast Imaging Service at the Memorial Sloan Kettering Cancer Center in New York, and colleagues.
(Editor's note: For related content, see "Current Insights on Breast Density, Contrast-Enhanced Mammography and Supplemental Breast Cancer Screening" and "Key Considerations with Implementing Contrast-Enhanced Mammography in Your Practice.")
Out of the nine CEM exams performed to assess the extent of breast cancer after neoadjuvant chemotherapy, the study authors noted the CEM findings were in concordance with contrast-enhanced breast magnetic resonance imaging (MRI) obtained within a seven-day window in these patients.
Acknowledging a small cohort size and a variety of CEM indications ranging from screening to post-chemotherapy assessment, Jochelson and colleagues said future research is necessary to clarify the effectiveness of CEM in patients with breast implants.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.